Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x100px
Document › Details

Merck KGaA. (2/1/17). "Press Release: Merck Appoints Anke Schenkel as Head of Group Controlling and Risk Management". Darmstadt.

Organisation Organisation Merck KGaA
  Group Merck (DE) (Group)
Products Product pharmaceutical

Merck, a leading science and technology company, today announced that with effect from April 1, Anke Schenkel (36) will assume the role of Head of Group Controlling & Risk Management. Schenkel will report to Marcus Kuhnert, Chief Financial Officer and member of the Executive Board of Merck.

Currently Head of Forecasting, Reporting & Governance in Controlling of Merck’s Healthcare business sector, Anke Schenkel will succeed Joachim Christ who will become Merck’s Chief Procurement Officer effective April 1, as announced previously.

“Our people are key to our success. We are therefore committed to developing and growing our employees and executives. I am pleased we could appoint an emerging leader with a proven track record from within Merck to this important role”, said Kuhnert.

Prior to joining Merck in 2010, Schenkel held various roles at PricewaterhouseCoopers. She has a Master’s degree in business administration awarded by the University of Mainz in Germany.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website Please go to to register online, change your selection or discontinue this service.

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Record changed: 2023-06-05


Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

More documents for Merck (DE) (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x300px

» top